The M3 Research Center
Malignome, Metabolome and Microbiome

Christoph Trautwein finished his first degree at the University Stuttgart in 2006 as environmental engineer (Dipl.-Ing.) where he specialized in analytical chemistry and environmental microbiology. Awarded with a scholarship from the German Environmental Agency (DBU) he started his PhD in 2007 at the University of Freiburg in collaboration with the University Hospital Freiburg. Herein he investigated the microbial degradation and distribution of drugs in the aquatic environment using chromatography coupled with ion trap and triple quadrupole mass spectrometry. Fascinated by the potential use of advanced analytical chemistry within clinical resaerch, he started a second career in Molecular Medicine at the same time. Christoph Trautweil obtained his doctor title in 2012 (Dr. rer. nat.) and graduated in 2014 as Dipl. mol. med. at the University of Freiburg. In order to expand his analytical knowledge towards NMR spectroscopy, he was working from 2015-2016 at the Karlsruhe Institute for Technology (KIT) as postdoc for NMR based metabolomics. In 2017, he joined the WSIC at the University Hospital Tübingen and since then build up the research field of preclinical and clinical metabolomics including a magnitude of internal and external collaborations. Since 2019 he is heading his own research group supported by the WSIC foundation and proper 3rd party funding. Currently he is in process of finalizing his habilitation and assembling the new metabolomics core facility at the M3 center equipped with latest ion mobility mass spectrometry and MALDI-2 technology.

ORCID: https://orcid.org/0000-0003-4672-6395

https://www.bruker.com/en/landingpages/bbio/resolution-in-a-new-dimension-for-solving-challenges-of-society/moving-metabolomics-up-a-gear.html

https://www.bruker.com/en/products-and-solutions/magnetic-resonance/make-mr-more-relevant/nmr-based-metabolomics-research-in-cancer.html